The Klinique, a Leading Medical Aesthetic Provider in Thailand, Visits LASEROPTEK to Strengthen Collaboration - ...
| KLINIQ Stock | 32.25 0.50 1.53% |
About 62% of Klinique Med's investor base is looking to short. The analysis of current outlook of investing in The Klinique Med suggests that many traders are alarmed regarding Klinique Med's prospects. The current market sentiment, together with Klinique Med's historical and current headlines, can help investors time the market. In addition, many technical investors use Klinique Med stock news signals to limit their universe of possible portfolio assets.
Klinique |
The Klinique, a Leading Medical Aesthetic Provider in Thailand, Visits LASEROPTEK to Strengthen Collaboration ...
Read at news.google.com
 |
Klinique Med Fundamental Analysis
We analyze Klinique Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klinique Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Klinique Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Klinique Med is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Klinique Med Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Klinique Med stock to make a market-neutral strategy. Peer analysis of Klinique Med could also be used in its relative valuation, which is a method of valuing Klinique Med by comparing valuation metrics with similar companies.
Peers
Klinique Med Related Equities
| SAPPE | Sappe Public | 2.25 | ||||
| GUNKUL | Gunkul Engineering | 1.74 | ||||
| AP | AP Public | 0.57 | ||||
| COM7 | Com7 PCL | 1.85 |
Complementary Tools for Klinique Stock analysis
When running Klinique Med's price analysis, check to measure Klinique Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klinique Med is operating at the current time. Most of Klinique Med's value examination focuses on studying past and present price action to predict the probability of Klinique Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klinique Med's price. Additionally, you may evaluate how the addition of Klinique Med to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |